Canepa M, Gambini C, Borgiani L, Pastorino A, Buccaran G, Gallo L, Storace A, Rovida S
Servizio di Anatomia Patologica, Ospedali Galliera di Genova.
Pathologica. 1993 Mar-Apr;85(1096):151-62.
By means of an AgNOR technique, the authors have carried out a retrospective study on proliferative activity in 170 cases of infiltrating ductal breast carcinoma (so-called carcinoma NOS). The follow-up period was 138 months. A statistically significant correlation was found between AgNOR score and outcome of the disease ("vital status"), clinical stage and OS respectively. By means of discriminant analysis a threshold value of AgNOR score was identified (= 9.5) which distinguished two risk groups among the cases under examination. Those cases with an average AgNOR score below the threshold value showed a favourable prognosis. The cases with an AgNOR score greater than 9.5 had an unfavourable outcome. The authors suggest that AgNOR score may be used as a prognostic parameter in breast carcinoma.
作者通过银染核仁组织区(AgNOR)技术,对170例浸润性导管癌(即所谓的非特殊型癌)的增殖活性进行了回顾性研究。随访期为138个月。分别发现AgNOR评分与疾病转归(“生存状态”)、临床分期及总生存期之间存在统计学显著相关性。通过判别分析确定了AgNOR评分的阈值(=9.5),该阈值区分了所检查病例中的两个风险组。平均AgNOR评分低于阈值的病例预后良好。AgNOR评分大于9.5的病例预后不良。作者建议AgNOR评分可作为乳腺癌的一个预后参数。